PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-May-2022 Medidata Recognized as a Program of the Year Winner at Forrester’s B2B Summit Businesswire
02-May-2022 Voxeleron Launches iNebula™, a Cloud-Based Platform for Optimized Ophthalmic Clinical Trial Workflow Businesswire
02-May-2022 Athersys to Participate in the Bank of America Securities 2022 Global Healthcare Conference Businesswire
02-May-2022 Innovaderm Honoured With a CRO Leadership Award Again This Year Businesswire
02-May-2022 Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COVID-19 Lung Damage Using its JadiCell™ Universal Donor Stem Cell Drug Businesswire
02-May-2022 Propanc Biopharma Purchases Pharma Grade Raw Materials for PRP Manufacture in Preparation for Phase I First-In-Human Study Businesswire
02-May-2022 insitro Announces Formation of Scientific Advisory Board to Support Platform and Pipeline Advancement Businesswire
02-May-2022 Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type 1 Diabetes Businesswire
02-May-2022 RHINOstic™ Automated Nasal Swab Earns Health Canada COVID-19 Interim Order No. 2 Medical Device Authorization Businesswire
02-May-2022 VistaGen Appoints Reid Adler as Chief Legal Officer Businesswire
02-May-2022 Meitheal Pharmaceuticals Announces Membership in The Association for Accessible Medicines Businesswire
02-May-2022 Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute Businesswire
02-May-2022 Arrowhead Pharmaceuticals Appoints Victoria Vakiener to Board of Directors Businesswire
02-May-2022 DTx Pharma Announces Appointment of Kathie M. Bishop to its Board of Directors Businesswire
02-May-2022 Santen’s Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% Now Available for the Treatment of Vernal Keratoconjunctivitis in Children and Adults in the United States Businesswire
02-May-2022 Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary Businesswire
02-May-2022 Can-Fite’s CEO to Present Namodenoson’s Efficacy in Liver Cancer as Expert Speaker at the Adenosine Pathway Targeted Cancer Immunotherapy Summit Businesswire
02-May-2022 Blue Spark Technologies Announces Appointment of John DeFord, Ph.D. to its Board of Directors Businesswire
02-May-2022 Enanta Pharmaceuticals to Host Conference Call on May 9 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2022 Businesswire
02-May-2022 Precision BioSciences to Report First Quarter 2022 Financial Results on May 9, 2022 Businesswire